Splenic irradiation in myelofibrosis. Clinical findings and ferrokinetics
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
Nine patients were submitted to splenic or, in two cases, hepatosplenic irradiation; these patients presented a primary myelofibrosis or a spent polycythemia vera characterized by splenomegaly, anemia, and occasionally leucocytosis and thrombocytopenia. The hematological condition returned to normal in 2 patients. This improvement lasted 4 years after a first series of irradiation. The recurrence of splenomegaly and anemia indicated a second series of irradiation, the results of which were as good as those of the first series. Ineffective medullary and splenic erythropoiesis without preeminent aplasia appeared to be correlated with a beneficial effect of splenic irradiation. Absence of hepatomegaly and marked leucocytosis were less important prognostic factors. The modee of action of radiotherapy and the way in which it differs from splenectomy are discussed. The irradiation delivered moderate doses (450 rad in 18 sessions of 25 rad). Hepatic irradiation did not appear to be essential even in cases of intense hepatic myeloid metaplasia: in 2 patients liver erythropoiesis regressed when the spleen alone was irradiated.
- Research Organization:
- Unite de Medecine Nucleaire de l'Institut Gustave-Roussy, Villejuif, France
- OSTI ID:
- 6781780
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 2:11-12; ISSN IOBPD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Ferrokinetic study of splenic erythropoiesis: Relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesis
Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea
Study of splenic irradiation in chronic lymphocytic leukemia
Journal Article
·
Sun Oct 01 00:00:00 EDT 1989
· American Journal of Hematology; (USA)
·
OSTI ID:5477185
Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea
Journal Article
·
Mon Sep 15 00:00:00 EDT 1986
· Cancer (Philadelphia); (United States)
·
OSTI ID:5005147
Study of splenic irradiation in chronic lymphocytic leukemia
Journal Article
·
Sat Dec 31 23:00:00 EST 1988
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6268822
Related Subjects
560151* -- Radiation Effects on Animals-- Man
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ABSCOPAL RADIATION EFFECTS
ANIMAL CELLS
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BLOOD FORMATION
BLOOD VESSELS
BODY
BONE MARROW CELLS
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
CONNECTIVE TISSUE CELLS
DISEASES
ERYTHROPOIESIS
FIBROSIS
FRACTIONATED IRRADIATION
HEMIC DISEASES
HYPERTENSION
IONIZING RADIATIONS
IRRADIATION
LEUKEMIA
LOCAL IRRADIATION
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATHOLOGICAL CHANGES
PATIENTS
POLYCYTHEMIA
PORTAL SYSTEM
RADIATION EFFECTS
RADIATIONS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
SIDE EFFECTS
SOMATIC CELLS
SPLEEN
SYMPTOMS
THERAPY
VASCULAR DISEASES
VEINS
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ABSCOPAL RADIATION EFFECTS
ANIMAL CELLS
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BLOOD FORMATION
BLOOD VESSELS
BODY
BONE MARROW CELLS
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
CONNECTIVE TISSUE CELLS
DISEASES
ERYTHROPOIESIS
FIBROSIS
FRACTIONATED IRRADIATION
HEMIC DISEASES
HYPERTENSION
IONIZING RADIATIONS
IRRADIATION
LEUKEMIA
LOCAL IRRADIATION
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATHOLOGICAL CHANGES
PATIENTS
POLYCYTHEMIA
PORTAL SYSTEM
RADIATION EFFECTS
RADIATIONS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
SIDE EFFECTS
SOMATIC CELLS
SPLEEN
SYMPTOMS
THERAPY
VASCULAR DISEASES
VEINS